SOX1 autoantibodies: tumor markers in LEMS patients?
Lang
Bethan
B
Evoli
Amelia
A
D001323:Autoantibodies / Q000276:immunology*; D014408:Biomarkers, Tumor / Q000032:analysis / Q000276:immunology*; D015220:Calcium Channels / Q000276:immunology; D018288:Carcinoma, Small Cell / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D004268:DNA-Binding Proteins / Q000235:genetics / Q000276:immunology*; D042241:Early Diagnosis; D006609:High Mobility Group Proteins / Q000235:genetics / Q000276:immunology*; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D008175:Lung Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D009457:Neuroglia / Q000276:immunology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology; D011237:Predictive Value of Tests; D011379:Prognosis; D055748:SOXB1 Transcription Factors
D001323:Autoantibodies; D014408:Biomarkers, Tumor; D015220:Calcium Channels; D004268:DNA-Binding Proteins; D006609:High Mobility Group Proteins; C490906:SOX1 protein, human; D055748:SOXB1 Transcription Factors